Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selective inhibition of leukemic cell proliferation by bcr-abl antisense oligonucleotides

Selective inhibition of leukemic cell proliferation by bcr-abl antisense oligonucleotides

US Patent 5652222 · Granted Jul 29, 1997

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Thrombopoietin receptor agonist (TpoRA) kills acute human myeloid leukemia cells2013
Methods of use of bcl-6-derived nucleotides to induce apoptosis2010
HIV-MSCV hybrid viral vector for gene transfer2001
Antisense of oligonucleotides to c-kit proto-oncogene and in vitro methods1999
Antisense of oligonucleotides to c-kit proto-oncogene and in vitro methods1999
DR-nm23 and compositions, methods of making and methods of using the same1998
Antisense oligonucleotides targeting cooperating oncogenes1998
Antisense oligonucleotides specific for STK-1 and method for inhibiting expressi1997
Selective inhibition of cell proliferation by vav antisense oligonucleotides1997
Suppression of megakaryocytopoiesis by neutrophil activating peptide-21995
Method for predicting the effectiveness of antineoplastic therapy in individual 1995
Method for predicting the effectiveness of antineoplastic therapy in individual 1995